Methotrexate as a Suspected Trigger of Macrophage Activation Syndrome in Juvenile Idiopathic Arthritis

Authors

  • Soumya Roy Institute Of Child Health, Kolkata
  • Subroto Chakrabartty Institute Of Child Health, Kolkata

DOI:

https://doi.org/10.3126/jnps.v37i1.16894

Keywords:

Macrophage activation syndrome, Methotrexate, Systemic Onset Juvenile Idiopathic Arthritis

Abstract

A four year old girl with systemic onset juvenile idiopathic arthritis (SOJIA) developed macrophage activation syndrome (MAS) shortly after starting methotrexate. We observed methotrexate is a likely trigger of MAS in SOJIA. Possibly, there are only two case reports suggesting methotrexate triggered MAS. We reviewed the literature for possible mechanisms.

Downloads

Download data is not yet available.
Abstract
980
PDF
784

Author Biographies

Soumya Roy, Institute Of Child Health, Kolkata

Post graduate trainee and junior resident,, Dept Of Paediatrics 

Subroto Chakrabartty, Institute Of Child Health, Kolkata

Professor Of Paediatrics

Downloads

Published

2017-10-04

How to Cite

Roy, S., & Chakrabartty, S. (2017). Methotrexate as a Suspected Trigger of Macrophage Activation Syndrome in Juvenile Idiopathic Arthritis. Journal of Nepal Paediatric Society, 37(1), 95–97. https://doi.org/10.3126/jnps.v37i1.16894

Issue

Section

Case Reports